Terminated PHASE3 INTERVENTIONAL 3-arm NCT00853567

Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids

A Phase III, Three-Arm, Parallel Design, Placebo-Controlled, Randomized, Double-Blind, Multicenter Study Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in the Treatment of Premenopausal Women With Symptomatic Uterine Fibroids

Sponsor: Repros Therapeutics Inc.

Conditions Uterine Fibroids

Interventions Proellex placebo

Updated 7 times since 2017 Last updated: Aug 5, 2014 Started: Feb 28, 2009 Primary completion: Aug 31, 2009 Completion: Aug 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Repros stopped the study for safety and FDA put the study on hold for safety.

Other terminated trials from Repros Therapeutics Inc.

More terminations from Repros Therapeutics Inc.

Other Uterine Fibroids trials with similar outcome

Browse all Uterine Fibroids trials

A PHASE3 clinical study on Uterine Fibroids, this trial is terminated or withdrawn. The trial is conducted by Repros Therapeutics Inc. and has accumulated 7 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Dec 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jan 2021 — Dec 2021 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Terminated PHASE3
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE3

First recorded

Feb 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Repros Therapeutics Inc.

Data source: Repros Therapeutics Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Anaheim, United States , Brooklyn, United States , Chattanooga, United States , Cleveland, United States , College Park, United States , Decatur, United States , Englewood, United States , Houston, United States , Los Angeles, United States , Louisville, United States and 3 more locations